Myocardial remodeling in hypertension

Journal of Human Hypertension

Volumn 29, Issue 1, 2015, Pages 1-6

  Nadruz, W ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; APOPTOSIS; ARTICLE; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; ETHNICITY; HEART ARRHYTHMIA; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEMODYNAMIC PARAMETERS; HEREDITY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; OBESITY; PHENOTYPE; PROGNOSIS; SALT INTAKE; SYSTOLIC DYSFUNCTION; WALL STRESS; ANIMAL; BLOOD PRESSURE; COMPLICATION; FIBROSIS; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; HYPERTROPHY, LEFT VENTRICULAR; PATHOLOGY; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; BLOOD PRESSURE; FIBROSIS; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84927175073     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.36     Document Type: Article

References (35)

1. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000; 35: 569-582.
2. Frohlich ED, Susic D. Pressure overload. Heart Fail Clin 2012; 8: 21-32.
3. Drazner MH. The progression of hypertensive heart disease. Circulation 2011; 123: 327-334.
4. Dávila DF, Donis JH, Odreman R, Gonzalez M, Landaeta A. Patterns of left ventricular hypertrophy in essential hypertension: should echocardiography guide the pharmacological treatment? Int J Cardiol 2008; 124: 134-138.
5. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
6. Díez J. Towards a new paradigm about hypertensive heart disease. Med Clin North Am 2009; 93: 637-645.
7. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141: 334-341.
8. Samuel JL, Swynghedauw B. Is cardiac hypertrophy a required compensatory mechanism in pressure-overloaded heart? J Hypertens 2008; 26: 857-858.
9. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 1997; 59: 551-571.
10. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens 2008; 21: 500-508.
11. Norton GR, Majane OH, Maseko MJ, Libhaber C, Redelinghuys M, Kruger D et al. Brachial blood pressure-independent relations between radial late systolic shoulder-derived aortic pressures and target organ changes. Hypertension 2012; 59: 885-892.
12. Gemignani T, Matos-Souza JR, Franchini KG, Nadruz Jr W. Leg blood pressure measured in orthostatic posture is associated with left ventricular mass in normotensive subjects. Am J Hypertens 2012; 25: 1083-1087.
13. Ruwhof C, van der Laarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 2000; 47: 23-37.
14. Velagaleti RS, Gona P, Levy D, Aragam J, Larson MG, Tofler GH et al. Relations of biomarkers representing distinct biological pathways to left ventricular geometry. Circulation 2008; 118: 2252-2258.
15. Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahlöf B, Devereux RB. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 2008; 9: 809-815.
16. Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA, Lima JA. LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. JACC Cardiovasc Imaging 2012; 5: 837-848.
17. Raman SV. The hypertensive heart. An integrated understanding informed by imaging. J Am Coll Cardiol 2010; 55: 91-96.
18. Coelho-Filho OR, Mongeon FP, Mitchell R, Moreno Jr H, Nadruz Jr W, Kwong R et al. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging 2013; 6: 134-141.
19. Coelho-Filho OR, Shah RV, Mitchell R, Neilan TG, Moreno Jr H, Simonson B et al. Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling. Circulation 2013; 128: 1225-1233.
20. Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens 2012; 26: 343-349.
21. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
22. Frisoli TM, Schmieder RE, Grodzicki T, Messerli FH. Salt and hypertension: is salt dietary reduction worth the effort? Am J Med 2012; 125: 433-439.
23. Reisin E, Jack AV. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am 2009; 93: 733-751.
24. de Simone G, Izzo R, De Luca N, Gerdts E. Left ventricular geometry in obesity: is it what we expect? Nutr Metab Cardiovasc Dis 2013; 23: 905-912.
25. Murarka S, Movahed MR. Diabetic cardiomyopathy. J Card Fail 2010; 16: 971-979.
26. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation 2001; 103: 102-107.
27. Arnett DK, de las Fuentes L, Broeckel U. Genes for left ventricular hypertrophy. Curr Hypertens Rep 2004; 6: 36-41.
28. Osler W. The Principles and Practice of Medicine. Appleton: New York, NY, USA, 1892.
29. Milani RV, Drazner MH, Lavie CJ, Morin DP, Ventura HO. Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction. Am J Cardiol 2011; 108: 992-996.
30. Krishnamoorthy A, Brown T, Ayers CR, Gupta S, Rame JE, Patel PC et al. Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up. Am J Cardiol 2011; 108: 997-1001.
31. Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D et al. Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. Am J Cardiol 2014; 113: 117-122.
32. Verdecchia P, Carini G, Circo A, Ciucci A, Battistelli M, Bartoccini C et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol 2001; 38: 1829-1835.
33. Verdecchia P, Angeli F, Borgioni C, Gattobigio R, de Simone G, Devereux RB et al. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens 2003; 16: 895-859.
34. Verdecchia P, Angeli F, Achilli P, Castellani C, Broccatelli A, Gattobigio R et al. Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events? Curr Opin Cardiol 2007; 22: 329-334.
35. Schäfer S, Kelm M, Mingers S, Strauer BE. Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens 2002; 20: 1431-1437.